NASDAQ:TYME - Tyme Technologies Stock Price, Forecast & News

Tyme Technologies trades on the NASDAQ under the ticker symbol "TYME."

Tyme Technologies Inc (NASDAQ:TYME) issued its quarterly earnings results on Monday, November, 4th. The company reported ($0.04) earnings per share for the quarter, topping the Thomson Reuters' consensus estimate of ($0.06) by $0.02. View Tyme Technologies' Earnings History.

Tyme Technologies is scheduled to release their next quarterly earnings announcement on Monday, February 10th 2020. View Earnings Estimates for Tyme Technologies.

1 analysts have issued twelve-month price objectives for Tyme Technologies' stock. Their forecasts range from $10.00 to $10.00. On average, they expect Tyme Technologies' share price to reach $10.00 in the next twelve months. This suggests a possible upside of 526.2% from the stock's current price. View Analyst Price Targets for Tyme Technologies.

1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Tyme Technologies in the last year. There are currently 1 buy rating for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Tyme Technologies.

Media stories about TYME stock have been trending somewhat negative recently, according to InfoTrie Sentiment. The research firm scores the sentiment of press coverage by monitoring more than six thousand blog and news sources. The firm ranks coverage of companies on a scale of negative five to five, with scores closest to five being the most favorable. Tyme Technologies earned a media sentiment score of -1.0 on InfoTrie's scale. They also gave media stories about the company a news buzz of 10.0 out of 10, indicating that recent press coverage is extremely likely to have an impact on the stock's share price in the next several days. View News Stories for Tyme Technologies.

Tyme Technologies saw a decrease in short interest in December. As of December 31st, there was short interest totalling 6,730,000 shares, a decrease of 5.2% from the December 15th total of 7,100,000 shares. Based on an average daily trading volume, of 448,600 shares, the short-interest ratio is currently 15.0 days. Currently, 13.1% of the company's stock are sold short. View Tyme Technologies' Current Options Chain.

Some companies that are related to Tyme Technologies include Vanda Pharmaceuticals (VNDA), Eagle Pharmaceuticals (EGRX), Stoke Therapeutics (STOK), CannTrust (CNTTF), Frequency Therapeutics (FREQ), Cytokinetics (CYTK), ANI Pharmaceuticals (ANIP), ImmunoGen (IMGN), Collegium Pharmaceutical (COLL), Homology Medicines (FIXX), Basilea Pharmaceutica (BPMUF), Flexion Therapeutics (FLXN), Akero Therapeutics (AKRO), Emisphere Technologies (EMIS) and Retrophin (RTRX).

Based on aggregate information from My MarketBeat watchlists, some companies that other Tyme Technologies investors own include Bausch Health Companies (BHC), Karyopharm Therapeutics (KPTI), OpGen (OPGN), Rigel Pharmaceuticals (RIGL), Aurora Cannabis (ACB), New Age Beverages (NBEV), AcelRx Pharmaceuticals (ACRX), Novavax (NVAX), Ovid Therapeutics (OVID) and Viking Therapeutics (VKTX).

Shares of TYME can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

One share of TYME stock can currently be purchased for approximately $1.60.

Tyme Technologies has a market capitalization of $178.77 million. The company earns $-32,980,000.00 in net income (profit) each year or ($0.32) on an earnings per share basis. Tyme Technologies employs 11 workers across the globe.View Additional Information About Tyme Technologies.

The official website for Tyme Technologies is http://www.tymeinc.com/.

Tyme Technologies' mailing address is 17 STATE STREET 7TH FLOOR, NEW YORK NY, 10004. The company can be reached via phone at 212-461-2315 or via email at [email protected]